Nielka P van Erp

22PUBLICATIONS
84CO-AUTHORS
Molecular targetsPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jul 02, 2026
Germline CDK12 variants in aggressive prostate cancer.

|May 04, 2026
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer.

|Jan 19, 2026
Mapping drug-drug interactions in pharmacokinetic boosting of olaparib.

Joanneke K Overbeek, Sarmad M S Naoom, Laura Nijboer

|Dec 02, 2025
Mitigating subtherapeutic cabozantinib exposure after prior mitotane therapy in adrenocortical carcinoma: Pharmacological boosting with cobicistat.

Annemieke M Peters van Ton, Nielka P van Erp, Annenienke C van de Ven

|Nov 23, 2025
Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer.

Catharina J P Op 't Hoog, Niven Mehra, Anouk van Kleef

|Jun 01, 2025
Exploring the Association Between Intra-Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients.

Amy Rieborn, Eline L Giraud, Teun van Gelder

Pageof 4

Frequent Collaborators

5 joint publications

Loek A W de Jong

4 joint publications

Eline L Giraud

4 joint publications

Emmy Boerrigter

3 joint publications

Niven Mehra